Search all medical codes

Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

HCPCS code

Name of the Procedure:

Budesonide, Inhalation Solution

  • Common Names: Budesonide Nebules, Pulmicort Respules
  • Technical/Medical Term: Budesonide inhalation solution for nebulization

Summary

Budesonide is a steroid medication available in an inhalation solution form, typically administered using a nebulizer. It helps reduce inflammation in the lungs, making it easier to breathe.

Purpose

The primary purpose of inhaled Budesonide is to manage respiratory issues by reducing inflammation and irritation in the airways.

  • Medical Conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD)
  • Goals: Alleviate symptoms such as wheezing, shortness of breath, and coughing; reduce the frequency of asthma attacks.

Indications

  • Symptoms warranting the procedure: Persistent asthma; COPD exacerbations
  • Patient Criteria: Individuals with chronic respiratory conditions not adequately controlled by other medications.

Preparation

  • Pre-procedure instructions: No specific fasting or medication adjustments required.
  • Diagnostic tests: Spirometry or other pulmonary function tests to assess lung function may be conducted to tailor the treatment.

Procedure Description

  1. The healthcare provider explains the procedure and checks the patient's nebulizer equipment.
  2. Budesonide solution is loaded into the nebulizer chamber.
  3. The patient is instructed to sit upright and place the nebulizer mouthpiece between the teeth, sealing lips around it.
  4. The nebulizer machine is turned on, converting the liquid medication into a fine mist.
  5. The patient inhales the mist slowly and deeply until all medication is nebulized (typically 5-10 minutes).
    • Tools: Nebulizer, Budesonide inhalation solution
    • Anesthesia: Not applicable

Duration

The entire administration process typically takes around 5 to 10 minutes.

Setting

The procedure can be performed in various settings, including:

  • Hospital
  • Outpatient clinic
  • Home (with proper instruction)

Personnel

  • Healthcare professionals involved: Respiratory therapists, nurses, or trained caregivers.
  • In home settings, patients or guardians can be taught to administer the medication properly.

Risks and Complications

  • Common Risks: Hoarseness, oral thrush, dry mouth, sore throat.
  • Rare Risks: Paradoxical bronchospasm (unexpected constriction of the airways).
  • Management: Rinsing mouth after inhalation to reduce the risk of oral thrush; immediate medical attention for severe reactions.

Benefits

  • Expected Benefits: Improved breathing, reduced symptoms of asthma/COPD, better overall respiratory function.
  • Onset of Benefits: Improvement can often be seen within 2 to 8 days of regular use.

Recovery

  • Post-procedure care: Rinse mouth with water after each session to prevent oral thrush.
  • Recovery time: No significant recovery period required post-inhalation.
  • Follow-up: Regular check-ups to monitor lung function and adjust dosage if necessary.

Alternatives

  • Other Treatment Options: Oral steroids, combination inhalers, other anti-asthmatic drugs.
  • Pros and Cons:
    • Oral Steroids: More systemic side effects.
    • Combination Inhalers: Convenient but may not provide enough control for all patients.
    • Other Anti-asthmatics: Depending on the specific medication, may have different side effect profiles or efficacy rates.

Patient Experience

  • During the Procedure: The patient might experience a cool or slightly bitter taste while inhaling the mist. They should breathe calmly and slowly.
  • After the Procedure: Possible mild throat irritation; should rinse mouth to prevent thrush. Regular monitoring to assess effectiveness and side effects.

Pain Management: Typically unnecessary, as the procedure is non-invasive and painless. Comfort measures include staying calm, sitting comfortably, and breathing normally.

Similar Codes